BeStock  
Stocks › Biotechnology › MAZE

Maze Therapeutics MAZE

US equityMarket cap rank #2785Biotechnology
$31.37 −$1.06 (-3.27%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $31.37 0.00%
Open$31.77
Prev close$32.43
Day range$30.88 – $32.80
Volume818.9K
Market cap$1.72B
P/E (TTM)–
Dividend yield–

MAZE Stock News

Headlines matching Maze Therapeutics or the MAZE ticker, most recent first.

  • Citi Initiates Maze Therapeutics(MAZE.US) With Buy Rating, Announces Target Price $50Market news · 24 Sep 2026 · Direct mention
  • HC Wainwright & Co. Reiterates Buy on Maze Therapeutics, Maintains $110 Price TargetBenzinga · 24 Sep 2026 · Direct mention
  • Wedbush Maintains Maze Therapeutics(MAZE.US) With Buy Rating, Maintains Target Price $48Market news · 23 Sep 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Maze Therapeutics, Inc. (MAZE), Viking Therapeutics (VKTX) and Aytu BioScience (AYTU)TipRanks · 23 Sep 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Maze Therapeutics, Inc. (MAZE) and Ionis Pharmaceuticals (IONS)TipRanks · 23 Sep 2026 · Direct mention
  • Analysts Are Bullish on Top Healthcare Stocks: Maze Therapeutics, Inc. (MAZE), Viking Therapeutics (VKTX) PositiveTipRanks · 23 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Maze Therapeutics(MAZE.US), With a Forecast Between $46 to $110Market news · 23 Sep 2026 · Direct mention
  • Analysts Are Bullish on Top Healthcare Stocks: Vertex Pharmaceuticals (VRTX), Maze Therapeutics, Inc. (MAZE) PositiveTipRanks · 22 Sep 2026 · Direct mention
  • Analysts Are Bullish on These Healthcare Stocks: Maze Therapeutics, Inc. (MAZE), Mirum Pharmaceuticals (MIRM) PositiveTipRanks · 10 Sep 2026 · Direct mention
  • Wells Fargo Maintains Maze Therapeutics(MAZE.US) With Buy Rating, Maintains Target Price $55Market news · 10 Sep 2026 · Direct mention
  • Truist Financial Maintains Maze Therapeutics(MAZE.US) With Buy Rating, Announces Target Price $64Market news · 14 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Maze Therapeutics(MAZE.US), With a Forecast Between $48 to $110Market news · 13 Aug 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Tango Therapeutics (TNGX), Maze Therapeutics, Inc. (MAZE) and Xtant Medical Holdings (XTNT)TipRanks · 12 Aug 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Maze Therapeutics, Inc. (MAZE) and Immunome (IMNM)TipRanks · 12 Aug 2026 · Direct mention
  • H.C. Wainwright Maintains Maze Therapeutics(MAZE.US) With Buy Rating, Maintains Target Price $110Market news · 11 Nov 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on MAZE.

Sign in to join the discussion.

Scroll to Top